Uterine cervix neoplasm
MONDO:0021230A neoplasm (disease) that involves the uterine cervix.
Also known as: Cervical neoplasm, cervical tumor, cervical tumour, cervix neoplasm, cervix tumor, cervix tumour, cervix uteri neoplasm, cervix uteri tumor
2123 clinical trials for this condition and its sub-types, 39 tagged with Uterine cervix neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uterine cervix neoplasm
-
Cervical cancer 576 trials · 700 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- High-grade neuroendocrine carcinoma of the cervix uteri 4 trials
- Malignant neoplasm of endocervix 0 trials · 4 incl. sub-types Sub-types →
- Cervix melanoma 1 trial
- Malignant mixed epithelial and mesenchymal tumor of cervix uteri 0 trials · 1 incl. sub-types Sub-types →
- Cervical Wilms tumor 0 trials
- Malignant germ cell tumor of cervix uteri 0 trials
- Sarcoma of cervix uteri 0 trials Sub-types →
- Uterine ligament cancer 0 trials Sub-types →
-
Cervical benign neoplasm 0 trials
4 sub-types
- Benign uterine ligament neoplasm 0 trials
- Cervical adenofibroma 0 trials
- Cervical mullerian papilloma 0 trials
- Cervix squamous papilloma 0 trials
-
Nabothian cyst 0 trials
-
Uterine ligament neoplasm 0 trials
4 sub-types
Most studied deeper sub-types
-
Vaccine trains immune system to target HPV-Linked cancers
Cure CompletedResearchers are testing a vaccine called BNT113 in people whose cancers are driven by HPV16, a common virus linked to head and neck, cervical, and anogenital tumors. The trial enrolls two groups: one with head and neck cancer that has been treated and shows no signs of disease, a…
Phase 1/2 • Sponsor: University of Southampton • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Immunotherapy boosts standard treatment for advanced cervical cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiation helps people with high-risk, locally advanced cervical cancer live longer without their cancer growing. About 1,060 participants received either pembrolizumab or a placebo alongside t…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Smarter screening: could a simple score reduce unnecessary biopsies?
Diagnosis CompletedThis study tested a new colposcopy method that uses a scoring system (Swede score) to better diagnose cervical precancer in women with abnormal screening results. Researchers enrolled 929 women referred for colposcopy to see if the scoring system could accurately identify precanc…
Sponsor: University of Aarhus • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
At-Home HPV test could save lives in underserved asian women
Prevention CompletedThis completed trial enrolled 797 Asian American women (Korean, Vietnamese, Chinese) aged 30-65 who were overdue for cervical cancer screening. All participants received community education and help scheduling a clinic screening. Half also got an HPV self-sampling kit to use at h…
Sponsor: Fox Chase Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Robotic surgery vs standard approaches: does the platform change cancer outcomes?
Knowledge-focused CompletedResearchers at a large hospital in Seoul reviewed records from nearly 33,000 adults who had curative-intent surgery for one of seven cancers in the abdomen or pelvis: pancreatic, gastric, rectal, cervical, endometrial, kidney, or prostate. They grouped patients by whether they re…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC